Identification of Novel Inhibitor of Protein Tyrosine Phosphatases Delta: Structure-Based Pharmacophore Modeling, Virtual Screening, Flexible Docking, Molecular Dynamics Simulation, and Post-Molecular Dynamics Analysis.

Owing to their unique functions in regulating the synapse activity of Protein Tyrosine Phosphatases Delta (PTPδ) that has drawn special attention for developing drugs to Autism Spectrum Disorders (ASDs). In this study, the PTPδ pharmacophore was first established by the structure based pharmacophore method. Subsequently, 10 compounds contented Lipinski's rule of five was acquired by the virtual screening of the PTPδ pharmacophore against ZINC and PubChem databases. Then, the 10 identified molecules were discovered that had better binding affinity than a known PTPδ inhibitors compound SCHEMBL16375396. Two compounds SCHEMBL16375408 and ZINC19796658 with high binding score, low toxicity were gained. They were observed by docking analysis and molecular dynamics simulations that the novel potential inhibitors not only possessed the same function as SCHEMBL16375396 did in inhibiting PTPδ, but also had more favorable conformation to bind with the catalytic active regions. This study provides a new method for identify PTPδ inhibitor for the treatment of ASDs disease.